Heat shock proteins, such as HSP40, HSP60, HSP70 and HSP90, are known as molecular chaperones because they play a role in helping proteins function properly when cells are under stress. The heat shock response protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes (the cell’s recycling system), which could otherwise lead to toxicity and disease.
Our work is focused on making use of the cell-protective properties of HSP70 to create new therapies for rare neurodegenerative diseases.
Orphazyme A/S Company announcement No. 01/2022 Inside information Company Registration No. 32266355 Net revenue range narrowed to DKK 35 – 37 million Operating expenses lowered to DKK 665 – 675 million, due to strict cost management Cash position as of December 31, 2021 , now anticipated to
Orphazyme A/S Company announcement No. 27/2021 Company Registration No. 32266355 Copenhagen – December 9 , 20 2 1 – Orphazyme A/S (ORPHA.CO; ORPH or the “Company”), a late-stage biopharmaceutical company, today announces changes to the Board of Directors, following Catherine Moukheibir’s decision
Orphazyme A/S Company announcement No. 26/2021 www.orphazyme.com Company Registration No. 32266355 Copenhagen – November 19 , 20 2 1 – Orphazyme A/S (ORPHA.CO; ORPH or the “Company”), a late-stage biopharmaceutical company, today announces that the company expects to publish financial
Our Research
For Investors & Media
Working at Orphazyme